Assessing the Accuracy of the NeuroBooster Array for GBA1 Variant Detection
Year: 2026
Type: preprint
Abstract: GBA1 variants are major Parkinson's disease risk factors, but their detection is challenging. We compared NeuroBooster Array (NBA) genotyping with reference sequencing in 3,744 individuals. NBA correctly identified 520/608 carriers (85.5%). Of 89 missed calls, 73 had no matching probe and 16 had missing calls. 25 participants had false positive calls. NBA should not be used alone for clinical decisions, but is very useful for case control analysis.
Source: medRxiv
Authors: Marco Toffoli, Laurel Screven, Aaron Jeffries, Raquel Real, Georgia Pittwood, Amelia Anderson, Selen Yalkic, Finlay Fraser, Jakub Stepniak, Ilaria Palmieri, Paola Dimartino, Enza Maria Valente, Global Parkinson's Genetics Program (GP2), Lara M Lange, Cornelis Blauwendraat, Huw R Morris, Anthony HV Schapira
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7225774603
Cites:
Cited by:
Related to: